The future of novel immunotherapies is bright, with ongoing research aimed at improving their efficacy, reducing side effects, and expanding their use to a broader range of cancers. Advances in understanding the tumor microenvironment and the development of combination therapies are expected to further enhance the effectiveness of these treatments.
